Literature DB >> 32909618

Semiparametric models and inference for the effect of a treatment when the outcome is nonnegative with clumping at zero.

Jing Cheng1, Dylan S Small2.   

Abstract

The outcome in a randomized experiment is sometimes nonnegative with a clump of observations at zero and continuously distributed positive values. One widely used model for a nonnegative outcome with a clump at zero is the Tobit model, which assumes that the treatment has a shift effect on the distribution of a normally distributed latent variable and the observed outcome is the maximum of the latent variable and zero. We develop a class of semiparametric models and inference procedures that extend the Tobit model in two useful directions. First, we consider more flexible models for the treatment effect than the shift effect of the Tobit model; for example, our models allow for the treatment to have a larger in magnitude effect for upper quantiles. Second, we make semiparametric inferences using empirical likelihood that allow the underlying latent variable to have any distribution, unlike the original Tobit model that assumes the latent variable is normally distributed. We apply our approach to data from the RAND Health Insurance Experiment. We also extend our approach to observational studies in which treatment assignment is strongly ignorable.
© 2020 The International Biometric Society.

Entities:  

Keywords:  Tobit model; causal inference; clump at zero; empirical likelihood; semicontinuous data

Mesh:

Year:  2020        PMID: 32909618      PMCID: PMC8349173          DOI: 10.1111/biom.13368

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  Reduced sensitivity to hidden bias at upper quantiles in observational studies with dilated treatment effects.

Authors:  P R Rosenbaum
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Causal mediation analyses with rank preserving models.

Authors:  Thomas R Ten Have; Marshall M Joffe; Kevin G Lynch; Gregory K Brown; Stephen A Maisto; Aaron T Beck
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

3.  Reduction in burden of illness: a new efficacy measure for prevention trials.

Authors:  M N Chang; H A Guess; J F Heyse
Journal:  Stat Med       Date:  1994-09-30       Impact factor: 2.373

4.  Evaluation of a brief tailored motivational intervention to prevent early childhood caries.

Authors:  Amid I Ismail; Steven Ondersma; Jenefer M Willem Jedele; Roderick J Little; James M Lepkowski
Journal:  Community Dent Oral Epidemiol       Date:  2011-03-29       Impact factor: 3.383

5.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

6.  A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

Authors:  Blaise Genton; Inoni Betuela; Ingrid Felger; Fadwa Al-Yaman; Robin F Anders; Allan Saul; Lawrence Rare; Moses Baisor; Kerry Lorry; Graham V Brown; David Pye; David O Irving; Thomas A Smith; Hans-Peter Beck; Michael P Alpers
Journal:  J Infect Dis       Date:  2002-02-14       Impact factor: 5.226

7.  Box-Cox transformation of left-censored data with application to the analysis of coronary artery calcification and pharmacokinetic data.

Authors:  Cong Han; Richard Kronmal
Journal:  Stat Med       Date:  2004-12-15       Impact factor: 2.373

8.  Chop-lump tests for vaccine trials.

Authors:  Dean Follmann; Michael P Fay; Michael Proschan
Journal:  Biometrics       Date:  2009-02-05       Impact factor: 2.571

9.  Health insurance and the demand for medical care: evidence from a randomized experiment.

Authors:  W G Manning; J P Newhouse; N Duan; E B Keeler; A Leibowitz; M S Marquis
Journal:  Am Econ Rev       Date:  1987-06

10.  Estrogen therapy and coronary-artery calcification.

Authors:  Joann E Manson; Matthew A Allison; Jacques E Rossouw; J Jeffrey Carr; Robert D Langer; Judith Hsia; Lewis H Kuller; Barbara B Cochrane; Julie R Hunt; Shari E Ludlam; Mary B Pettinger; Margery Gass; Karen L Margolis; Lauren Nathan; Judith K Ockene; Ross L Prentice; John Robbins; Marcia L Stefanick
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

  10 in total
  1 in total

1.  Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients.

Authors:  Catherine L Auriemma; Stephanie P Taylor; Michael O Harhay; Katherine R Courtright; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2021-10-15       Impact factor: 30.528

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.